Angelo Blasio - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Angelo Blasio

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Disease Models & Mechanisms|August 5, 2021

Recessive, gain-of-function toxicity in an APOL1 BAC transgenic mouse model mirrors human APOL1 kidney diseaseGizelle M McCarthy, Angelo Blasio, Olivia G Donovan, et al.

Pflugers Archiv : European Journal of Physiology|November 30, 2022

Apolipoprotein L1 (APOL1) cation current in HEK-293 cells and in human podocytesDavid H Vandorpe, John F Heneghan, Joshua S Waitzman, et al.

Nature Communications|January 2, 2025

Small molecule APOL1 inhibitors as a precision medicine approach for APOL1-mediated kidney diseaseBrandon Zimmerman, Leslie A Dakin, Anne Fortier, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Disease Models & Mechanisms|August 5, 2021

Recessive, gain-of-function toxicity in an APOL1 BAC transgenic mouse model mirrors human APOL1 kidney diseaseGizelle M McCarthy, Angelo Blasio, Olivia G Donovan, et al.

Pflugers Archiv : European Journal of Physiology|November 30, 2022

Apolipoprotein L1 (APOL1) cation current in HEK-293 cells and in human podocytesDavid H Vandorpe, John F Heneghan, Joshua S Waitzman, et al.

Nature Communications|January 2, 2025

Small molecule APOL1 inhibitors as a precision medicine approach for APOL1-mediated kidney diseaseBrandon Zimmerman, Leslie A Dakin, Anne Fortier, et al.

Pageof 3